Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G

Passive or exempt beneficial ownership filing.

Ownership

10%

Beneficial ownership of this reported class.

Shares

7,000,000 shares

Shares beneficially owned as disclosed.

Event date

18 Sep 2025

Date tied to the ownership event or amendment.

Accepted by SEC

23 Sep 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
VOR
Shares outstanding
70,070,070 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13G
Accepted by SEC
23 Sep 2025, 16:00:02 UTC
Event date
18 Sep 2025
Next SEC filing
23 Dec 2025
Source filing
View source filing

Key filing fact

ForGrowth III PA B.V. disclosed 10% ownership in Vor Biopharma Inc. Common Stock, $0.0001 par value per share (VOR) on 18 Sep 2025.

Key facts

  • ForGrowth III PA B.V. filed SCHEDULE 13G for Vor Biopharma Inc. Common Stock, $0.0001 par value per share (VOR).
  • Disclosed ownership: 10%.
  • Date of event: 18 Sep 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 23 Sep 2025, 16:00.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (3)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
ForGrowth III PA B.V. 10% 7,000,000 0 7,000,000 /s/ V. van Houten and /s/ G.J. Mulder V. van Houten and G.J. Mulder, Directors of its Director
Forbion Growth Opportunities Fund III Cooperatief U.A. 10% 7,000,000 0 7,000,000 /s/ V. van Houten and /s/ G.J. Mulder V. van Houten and G.J. Mulder, Directors of its Director
Forbion Growth III Management B.V. 10% 7,000,000 0 7,000,000 /s/ V. van Houten and /s/ G.J. Mulder V. van Houten and G.J. Mulder, Directors
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .